| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | David S Stephens | |
| Shanta M Zimmer | |||
| P433 | issue | 8 | |
| P304 | page(s) | 733-739 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Current Opinion in Investigational Drugs | Q15724634 |
| P1476 | title | Serogroup B meningococcal vaccines | |
| P478 | volume | 7 |
| Q37126987 | Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin |
| Q37426039 | Carbohydrate vaccines: developing sweet solutions to sticky situations? |
| Q39667409 | Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence |
| Q41307878 | Expression of phosphofructokinase in Neisseria meningitidis |
| Q34632986 | Neisseria meningitidis: biology, microbiology, and epidemiology. |
| Q35887397 | Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant |
| Q54255446 | Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. |
| Q38531723 | Regulation of capsule in Neisseria meningitidis |
Search more.